Proteotype Diagnostics Selected for EU-Funded HER-CARE Doctoral Network, Signalling Growing Research Leadership in Precision Oncology

Contributed by: PR Newswire

Images

PR Newswire associated0
PR Newswire associated1

Tags

Proteotype-EU

More Like This

PR Newswire associated0

Proteotype Awarded £1.5 Million Grant to Advance Early Cancer Detection with Innovative Enlighten® Test

PR Newswire associated0

Innovative Immunodiagnostic Platform Unveils Highly Sensitive Cancer Early-Detection Test with Predictive Treatment Insights

PR Newswire associated0

Proteotype Launches €3 Million European Study to Advance Multi-Cancer Detection and Evaluate Home Blood Collection

PR Newswire associated0

Trial Evaluating Blood Test for 10 Cancers Reaches Major Milestone

PR Newswire associated0

Menarini Silicon Biosystems announces publication of the DETECT III trial results highlighting the potential clinical utility of HER2 testing in circulating tumor cells with CELLSEARCH

Business Wire logo

DEFINITIVE Trial Reaches Major Milestone: All Centres Approved and More Than 50% Recruitment Achieved

PR Newswire associated0

Proteotype Unveils Alchemi®, the Data and Orchestration Platform Behind Enlighten®

NeutroFlow: Leading European Medical Consortium Awarded €2.5 Million Grant from EIC Transition Programme to Advance Predictive Biomarker Development for Immunotherapy Response